Literature DB >> 24599358

Diffuse soft tissue and vascular calcification in systemic lupus erythematosus with chronic kidney disease.

F Yıldız1, B Kelle, D A Taş, B Kaya, E Altun, E Erken.   

Abstract

The systemic disorder of mineral and bone metabolism which is related to chronic kidney disease (CKD) is called mineral and bone disorder (MBD). Calcifications related to CKD-MBD may occur in ophthalmic tissue, arterial walls, subcutaneous and periarticular soft tissues and organs. The vascular calcifications are the most important causes of mortality and morbidity in CKD. Here, we present a case of systemic lupus erythematosus with early and disseminated calcifications of vascular and periarticular soft tissues related to CKD-MBD.

Entities:  

Mesh:

Year:  2014        PMID: 24599358     DOI: 10.1007/s00393-014-1355-6

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  12 in total

1.  Soft tissue calcification in pediatric patients with end-stage renal disease.

Authors:  D S Milliner; A R Zinsmeister; E Lieberman; B Landing
Journal:  Kidney Int       Date:  1990-11       Impact factor: 10.612

2.  Severe calcification of the arteries.

Authors:  Naohiko Imai; Motonori Nagasawa; Kenjiro Kimura
Journal:  Intern Med       Date:  2012-06-01       Impact factor: 1.271

3.  K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients.

Authors: 
Journal:  Am J Kidney Dis       Date:  2005-04       Impact factor: 8.860

Review 4.  Vascular imaging in chronic kidney disease.

Authors:  Antonio Bellasi; Paolo Raggi
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-07       Impact factor: 2.894

Review 5.  Chronic kidney disease-mineral-bone disorder: a new paradigm.

Authors:  Sharon M Moe; Tilman Drüeke; Norbert Lameire; Garabed Eknoyan
Journal:  Adv Chronic Kidney Dis       Date:  2007-01       Impact factor: 3.620

6.  Treatment with pyrophosphate inhibits uremic vascular calcification.

Authors:  W Charles O'Neill; Koba A Lomashvili; Hartmut H Malluche; Marie-Claude Faugere; Bruce L Riser
Journal:  Kidney Int       Date:  2010-12-01       Impact factor: 10.612

7.  Premature coronary-artery atherosclerosis in systemic lupus erythematosus.

Authors:  Yu Asanuma; Annette Oeser; Ayumi K Shintani; Elizabeth Turner; Nancy Olsen; Sergio Fazio; MacRae F Linton; Paolo Raggi; C Michael Stein
Journal:  N Engl J Med       Date:  2003-12-18       Impact factor: 91.245

8.  Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease.

Authors:  A S Levey; J A Beto; B E Coronado; G Eknoyan; R N Foley; B L Kasiske; M J Klag; L U Mailloux; C L Manske; K B Meyer; P S Parfrey; M A Pfeffer; N K Wenger; P W Wilson; J T Wright
Journal:  Am J Kidney Dis       Date:  1998-11       Impact factor: 8.860

Review 9.  Musculoskeletal manifestations of chronic renal insufficiency.

Authors:  M D Murphey; D J Sartoris; J L Quale; M N Pathria; N L Martin
Journal:  Radiographics       Date:  1993-03       Impact factor: 5.333

10.  [Non invasive evaluation of vascular calcifications in patients on hemodyalisis].

Authors:  H Resić; F Masnić; S Ajanović; N Kukavica; N Prohić; A Corić; A Bećiragić
Journal:  Acta Med Croatica       Date:  2011-10
View more
  1 in total

Review 1.  Systemic lupus erythematosus-related hypercalcemia with ectopic calcinosis.

Authors:  Lidan Zhao; Linfang Huang; Xuan Zhang
Journal:  Rheumatol Int       Date:  2016-05-02       Impact factor: 2.631

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.